Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros

Bases de dados
Ano de publicação
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
Am J Vet Res ; 73(11): 1787-93, 2012 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-23106465

RESUMO

OBJECTIVE: To assess long-term effects and risk factors for the efficacy of hyperimmunization protocols against infectious bovine rhinotracheitis (IBR) during a longitudinal field study of dairy and dairy-beef mixed farms. ANIMALS: Approximately 7,700 cows from 72 farms. PROCEDURES: Farms were assigned to 3 treatment groups (hyperimmunization groups [HIGs] 1 and 2, which were hyperimmunized with glycoprotein E [gE]-deleted marker vaccines, and a nonintervention group [NIG]). Cattle in HIG 1 were initially vaccinated with an attenuated vaccine, whereas cattle in HIG 2 were initially vaccinated with an inactivated-virus vaccine. Cattle in both HIGs received booster inoculations with inactivated-virus vaccines at 6-month intervals. The risk for gE seroconversion was compared among experimental groups via a shared frailty model with a piecewise constant baseline risk to correct for seasonal and secular effects. RESULTS: Risk for gE seroconversion significantly decreased over time for the HIGs, compared with the NIG. Seasonal changes in the risk of gE seroconversion were detected, with a higher risk during winter periods, compared with grazing periods. No significant difference was detected between HIGs 1 and 2. The only significant risk factor was the number of buildings for cattle on a farm; the higher the number of buildings, the lower the risk for gE seroconversion. Prevalence of IBR decreased over time in both HIGs but remained constant or increased in the NIG. CONCLUSIONS AND CLINICAL RELEVANCE: Hyperimmunization via repeated administration of attenuated and inactivated-virus gE-deleted marker vaccines as well as inactivated-virus vaccines may provide a method for control of IBR.


Assuntos
Herpesvirus Bovino 1/genética , Herpesvirus Bovino 1/imunologia , Rinotraqueíte Infecciosa Bovina/prevenção & controle , Proteínas Virais/genética , Vacinas Virais/imunologia , Animais , Anticorpos Antivirais , Bovinos , Feminino , Imunização Secundária , Rinotraqueíte Infecciosa Bovina/transmissão , Rinotraqueíte Infecciosa Bovina/virologia , Masculino , Fatores de Risco , Fatores de Tempo , Vacinas de Produtos Inativados
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA